KFAS
PRAX icon

Keating Financial Advisory Services’s Praxis Precision Medicines PRAX Stock Holding History

Keating Financial Advisory Services’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.35K Buy
10
+2
+25% +$633 ﹤0.01% 1731
2026
Q1 		$2.58K Buy
8
+7
+700% +$2.17K ﹤0.01% 1748
2025
Q4 		$295 Buy
+1
New +$186 ﹤0.01% 2024

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Keating Financial Advisory Services's PRAX Position: Q2 2026 in Review

Keating Financial Advisory Services increased its Praxis Precision Medicines (PRAX) stake by 25% in Q2 2026, buying an estimated $633 and bringing the position to 10 shares worth $3.35K. The position accounts for ﹤0.01% of the portfolio, ranked #1731.

Keating Financial Advisory Services first reported a position in PRAX in Q4 2025 and has held it in 3 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Keating Financial Advisory Services held 10 shares of Praxis Precision Medicines worth $3.35K as of Q2 2026.
  • Keating Financial Advisory Services bought 2 Praxis Precision Medicines shares in Q2 2026, an estimated $633.
  • Praxis Precision Medicines made up ﹤0.01% of Keating Financial Advisory Services's portfolio in Q2 2026, its #1731 holding.
  • Keating Financial Advisory Services first reported a position in Praxis Precision Medicines in Q4 2025 and has held it in 3 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.